-
21
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis
Published 2013-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
22
Extrahepatic portosystemic shunts as an unusual but treatable cause of hyperammonemic encephalopathy in a noncirrhotic patient – a case report
Published 2022-05-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
23
What are the therapeutic advances in neurology? Opinions from world experts
Published 2008-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
24
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment
Published 2015-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
25
Practical considerations on the use of rituximab in autoimmune neurological disorders
Published 2010-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
26
Current therapeutic approaches to diffuse grade II and III gliomas
Published 2018-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
27
Fingolimod in the treatment of relapsing–remitting multiple sclerosis: long-term experience and an update on the clinical evidence
Published 2016-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
28
Oropharyngeal swab for SARS-CoV-2 test causing atypical internal carotid artery dissection and stroke in a patient after mild COVID-19
Published 2021-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
29
Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy
Published 2020-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
30
Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis
Published 2019-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
31
Cerebral venous thrombosis in women of childbearing age: diagnosis, treatment, and prophylaxis during a future pregnancy
Published 2020-08-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
32
Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke
Published 2021-08-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
33
Review: Progress in the management of paraneoplastic neurological disorders
Published 2010-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
34
Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN
Published 2018-08-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
35
Editorial
Published 2008-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
36
Long-term use of proton-pump inhibitor on Alzheimer’s disease: a real-world distributed network analysis of six observational Korean databases using a Common Data Model
Published 2022-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
37
Differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis
Published 2020-08-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
38
Immunological and non-immunological effects of stem cell-derived extracellular vesicles on the ischaemic brain
Published 2018-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
39
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial
Published 2021-04-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
40
Vigabatrin-associated brain abnormalities on MRI in tuberous sclerosis complex patients with infantile spasms: are they preventable?
Published 2022-12-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article